iData's comprehensive European Markets for Spinal Implants and VCF 2010 report is the industry leading research report for actionable market intelligence in the changing and exciting European spine industry. This report denotes key data points, market trends, and in-depth analysis for the following market segments: - Cervical fusion, - Thoracolumbar fusion, - Interbody fusion (including stand-alone interbody devices), - Vertebroplasty, - Kyphoplasty, - Artificial discs, - Interspinous distraction devices, - Dynamic stabilization, - Annular repair, - Nucleus replacement, - Facet arthroplasty and lumbar and - Cervical electrical stimulation devices.This report also includes key data from the minimally invasive spinal (MIS) fusion market, including XLIF, AxiaLIF, GLIF, DLIF, MIS PLIF and MIS TLIF approaches.The report covers: - Austria - Benelux - France - Germany - Portugal - Scandinavia - Spain - Switzerland - The United KingdomThe European spinal implant markets are expected to exceed '1 billion by 2017,driven by growth in non-fusion devices. Within the European spinal implant market, companies such as Depuy, Medtronic, Stryker, Synthes and Zimmer lead the market, among others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available.
European Markets for Dental Bone Graft Substitutes, Dental Membranes and Tiss...ReportLinker.com
In 2010, the total European markets for dental bone graft substitutes and other biomaterials grew by 4.4% over 2009 and were valued at nearly '232 million. This market includes: - Austria - Benelux - France - Germany - Italy - Portugal - Scandinavia - Spain - Switzerland - U.K. This report also includes the following market segments: - Dental Bone Graft Substitute Market - Dental Autograft Potential Market - Dental Xenograft Market - Synthetic Bone Graft Substitute Materials Market - Dental Membrane Market Within the dental bone graft substitute market, companies such as Biomet-3i, Geistlich, Riemser (Curasan) and Non-Profit Tissue Banks lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available for purchase.
European Markets for Orthopedic Large Joint Reconstructive Devices 2011ReportLinker.com
In 2010, the combined European large joint orthopedic reconstruction device market was valued at over '1.9 billion. The countries covered in this report include: - Austria - Benelux - France - Germany - Italy - Portugal - Scandinavia - Spain - Switzerland - The United KingdomDespite the lower average selling prices offered in the German reconstruction device market, which had the most challenging pricing environment, it was the largest combined hip and knee reconstruction device market in Europe. Comparatively, the average price for orthopedic implants in Germany was lower than for Portugal, which has a significantly lower national income per capita. The market segments covered in this report include: - The knee reconstruction market - The hip reconstruction market - The bone cement marketWithin the orthopedic large joint replacement and bone cement market, companies such as Biomet, DePuy Orthopaedics, Smith & Nephew, Stryker Orthopedics and Zimmer lead the market, among others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.
Asia Pacific Markets for Orthopedic Large Joint Reconstructive Devices 2011ReportLinker.com
In 2010, the combined markets for large joint implants in Australia, Japan and South Korea were valued at over US$1.65 billion. Hip and knee replacement implants represent a significant portion of healthcare expenditures in the Asia-Pacific region. This report describes three Asia-Pacific countries in detail; however, trends in device usage are unique to each country, with each medical community favoring different variations of hip and knee implants. The prostheses covered include total joint, partial, resurfacing and revision types of implants, as well as trends in bone cement usage and bearing surface technologies. Within the Asia Pacific orthopedic large joint reconstructive device market, companies such as Depuy, Japan Medical Materials Corporate (JMMC), Smith & Nephew, Stryker and Zimmer lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available.
European Markets for Dental Bone Graft Substitutes, Dental Membranes and Tiss...ReportLinker.com
In 2010, the total European markets for dental bone graft substitutes and other biomaterials grew by 4.4% over 2009 and were valued at nearly '232 million. This market includes: - Austria - Benelux - France - Germany - Italy - Portugal - Scandinavia - Spain - Switzerland - U.K. This report also includes the following market segments: - Dental Bone Graft Substitute Market - Dental Autograft Potential Market - Dental Xenograft Market - Synthetic Bone Graft Substitute Materials Market - Dental Membrane Market Within the dental bone graft substitute market, companies such as Biomet-3i, Geistlich, Riemser (Curasan) and Non-Profit Tissue Banks lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available for purchase.
European Markets for Orthopedic Large Joint Reconstructive Devices 2011ReportLinker.com
In 2010, the combined European large joint orthopedic reconstruction device market was valued at over '1.9 billion. The countries covered in this report include: - Austria - Benelux - France - Germany - Italy - Portugal - Scandinavia - Spain - Switzerland - The United KingdomDespite the lower average selling prices offered in the German reconstruction device market, which had the most challenging pricing environment, it was the largest combined hip and knee reconstruction device market in Europe. Comparatively, the average price for orthopedic implants in Germany was lower than for Portugal, which has a significantly lower national income per capita. The market segments covered in this report include: - The knee reconstruction market - The hip reconstruction market - The bone cement marketWithin the orthopedic large joint replacement and bone cement market, companies such as Biomet, DePuy Orthopaedics, Smith & Nephew, Stryker Orthopedics and Zimmer lead the market, among others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.
Asia Pacific Markets for Orthopedic Large Joint Reconstructive Devices 2011ReportLinker.com
In 2010, the combined markets for large joint implants in Australia, Japan and South Korea were valued at over US$1.65 billion. Hip and knee replacement implants represent a significant portion of healthcare expenditures in the Asia-Pacific region. This report describes three Asia-Pacific countries in detail; however, trends in device usage are unique to each country, with each medical community favoring different variations of hip and knee implants. The prostheses covered include total joint, partial, resurfacing and revision types of implants, as well as trends in bone cement usage and bearing surface technologies. Within the Asia Pacific orthopedic large joint reconstructive device market, companies such as Depuy, Japan Medical Materials Corporate (JMMC), Smith & Nephew, Stryker and Zimmer lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available.
European Markets for Interventional Cardiology Devices 2011 (15 Countries)ReportLinker.com
In 2010, the European markets for interventional cardiology devices were valued at over '1.5 billion. In 2010, the fastest growing European market for interventional cardiology devices as the United Kingdom. Over the forecast period, Scandinavia is expected to be the fastest growing market in Europe because it has relatively low DES penetration rates; as these penetration rates increase, they will boost market growth. Growth in countries such as Austria, France, and Switzerland are expected to slow over the forecast period due to decreases in prices across several device markets. The European markets, as defined in this report, include: - Germany, - France, - The United Kingdom (U.K.), - Italy, - Spain, - Benelux (Belgium, Netherlands, and Luxembourg), - Scandinavia (Finland, Denmark, Sweden, and Norway), - Portugal, - Austria and - SwitzerlandThe interventional cardiology market includes: - Drug-eluting stents, - Bare-metal stents, - PTCA balloon catheters, - Interventional coronary catheters and guidewires, - Diagnostic coronary catheters and guidewires, - Coronary introducer sheaths, - Embolic protection devices, - Atherectomy devices, - Coronary vascular closure devices, - Optical coherence tomography (OCT) catheters - Intravascular ultrasound (IVUS) cathetersIn addition, this report covers the emerging markets for vulnerable plaque screening and treatment. Within the European interventional cardiology market, companies such as Boston Scientific, Abbott Laboratories, Cordis and Medtronic lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available for purchase.
European Market for Cardiac Rhythm Management, Electrophysiology & Ablation D...ReportLinker.com
European Market for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 (15 countries) In 2010, the European market for cardiac rhythm management, electrophysiology, and ablation devices was valued at over '2.3 billion ($3.09 billion). The fastest growth was expected in the diagnostic electrophysiology (EP) catheter market and the slowest growth was expected in the external defibrillators market. None of the markets covered in this report are expected to decline over the forecast period. The countries covered in this report include: - Germany - France - U.K - Italy - Spain - Benelux - Scandinavia - Portugal - Austria - SwitzerlandThe market segments in this report include: - Pacemakers, - Implantable cardioverter-defibrillators (ICDs), - Cardiac resynchronization therapy devices (CRTs), - Cardiac leads, - External defibrillators, - Ablation catheters, - Intracardiac echocardiography (ICE) catheters and - Diagnostic electrophysiology (EP) cathetersWithin the cardiac rhythm management, electrophysiology, and ablation device market, companies such as Biotronik, Boston Scientific, Medtronic and St. Jude Medical lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available for purchase.
In 2010, the European market for cardiac surgery devices was valued at over'990 millionThe European markets for cardiac surgery devices includes: - Mechanical Heart Valves - Annuloplasty Repair Devices - Percutaneous Mitral Valve Repair Devices (PMVR) - Percutaneous Aortic Valve Replacement Devices (PAVR) - ONCAB Devices - OPCAB Devices - Endoscopic Vessel Harvesting Devices - Anastomosis Assist Devices - Cardiac Ablation Devices - Transmyocardial Revascularization Devices - Ventricular Assist Devices - Intra-Aortic Balloon Pump Devices - Artificial Heard Devices - Patient Foramen Ovale Devices - Atrial and Ventricular Septal DevicesThe countries covered in this report include: - Germany - France - U.K - Italy - Spain - Benelux - Scandinavia - Portugal - Austria - SwitzerlandWithin the European cardiac surgery device market, companies such as Edwards Lifesciences, Maquet, Medtronic, Sorin and St. Jude lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available for purchase.
Asia-Pacific Markets for Patient Monitoring Devices 2011ReportLinker.com
The total Asia-Pacific patient monitoring market is expected to exceed $598 million by 2017. The Australian home telehealth market experienced the greatest growth in revenues of over 90% in 2010, followed by the Japanese wireless ambulatory telemetry market. Growth is being fueled by efforts of healthcare facilities to decrease costs and compensate for staff shortages by using technology to increase patient mobility and discharge patients sooner. In addition, wireless telemetry monitoring in the Asia-Pacific region was primarily utilized in cardiac care-related areas in 2010. However, expansion of telemetry to other hospital departments that previously did not have monitoring, many of which are low-acuity settings, is expected to drive growth in this market by 2017.The Asia-Pacific markets for patient monitoring devices includes the following countries: - Japan - Australia - South KoreaThe market segments covered in this report include: - Multi-parameter vital sign monitors - Intra-cranial pressure monitors and consumables - Electromyogram devices and consumables - Electroencephalogram monitors - Sleep apnea monitors - Cerebral oximeter monitors and consumables - Fetal and neonatal monitors - Pulse oximeter monitors, consumables and circuit boards - Cardiac output devices and consumables - Blood pressure monitorsWithin the Asia-Pacific patient monitoring market, companies such as Nihon Kohden, GE Healthcare and Philips Healthcare lead the market, among others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available for purchase.
Asia-Pacific Markets for Patient Monitoring Devices 2011ReportLinker.com
The total Asia-Pacific patient monitoring market is expected to exceed $598 million by 2017. The Australian home telehealth market experienced the greatest growth in revenues of over 90% in 2010, followed by the Japanese wireless ambulatory telemetry market. Growth is being fueled by efforts of healthcare facilities to decrease costs and compensate for staff shortages by using technology to increase patient mobility and discharge patients sooner. In addition, wireless telemetry monitoring in the Asia-Pacific region was primarily utilized in cardiac care-related areas in 2010. However, expansion of telemetry to other hospital departments that previously did not have monitoring, many of which are low-acuity settings, is expected to drive growth in this market by 2017.The Asia-Pacific markets for patient monitoring devices includes the following countries: - Japan - Australia - South KoreaThe market segments covered in this report include: - Multi-parameter vital sign monitors - Intra-cranial pressure monitors and consumables - Electromyogram devices and consumables - Electroencephalogram monitors - Sleep apnea monitors - Cerebral oximeter monitors and consumables - Fetal and neonatal monitors - Pulse oximeter monitors, consumables and circuit boards - Cardiac output devices and consumables - Blood pressure monitorsWithin the Asia-Pacific patient monitoring market, companies such as Nihon Kohden, GE Healthcare and Philips Healthcare lead the market, among others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available for purchase.
Asia-Pacific Markets for Patient Monitoring Devices 2011ReportLinker.com
The total Asia-Pacific patient monitoring market is expected to exceed $598 million by 2017. The Australian home telehealth market experienced the greatest growth in revenues of over 90% in 2010, followed by the Japanese wireless ambulatory telemetry market. Growth is being fueled by efforts of healthcare facilities to decrease costs and compensate for staff shortages by using technology to increase patient mobility and discharge patients sooner. In addition, wireless telemetry monitoring in the Asia-Pacific region was primarily utilized in cardiac care-related areas in 2010. However, expansion of telemetry to other hospital departments that previously did not have monitoring, many of which are low-acuity settings, is expected to drive growth in this market by 2017.The Asia-Pacific markets for patient monitoring devices includes the following countries: - Japan - Australia - South KoreaThe market segments covered in this report include: - Multi-parameter vital sign monitors - Intra-cranial pressure monitors and consumables - Electromyogram devices and consumables - Electroencephalogram monitors - Sleep apnea monitors - Cerebral oximeter monitors and consumables - Fetal and neonatal monitors - Pulse oximeter monitors, consumables and circuit boards - Cardiac output devices and consumables - Blood pressure monitorsWithin the Asia-Pacific patient monitoring market, companies such as Nihon Kohden, GE Healthcare and Philips Healthcare lead the market, among others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available for purchase.
European Markets for Anesthesia, Respiratory and Sleep Apnea Devices 2011ReportLinker.com
In 2011, the European Market for Anesthesia, Respiratory and Sleep Management Devices was valued at over $1.4 billion. By 2017, this market is expected to reach almost $2 billion, fueled by growth in the sleep therapy device and ventilator segments, the market is expected to increase over the forecast period. As the population increases in age, the prevalence of sleep disorders is expected to grow accordingly. The European population is also becoming more aware of sleep disorders and the risks associated with not receiving proper treatment, which will drive the total market for anesthesia, respiratory and sleep management devices. In addition, technological advancements such as remote monitoring and homecare devices are expected to further fuel growth. The market segments covered in this report include: - Anesthesia Delivery Units - Anesthesia Delivery Market - Anesthesia Disposables - Ventilators - Nebulizers - Respiratory Disposables - Sleep Diagnostic Devices - Sleep Therapy Devices The countries covered in this report include: - Austria - Benelux - France - Germany - Italy - Portugal - Scandinavia - Spain - Switzerland - The United KingdomThis report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.
This TriMark Publications report deals primarily with the analysis of market segments of microscopes used in clinical and research laboratories. Emphasis is on the U.S. markets; however, the worldwide markets are analyzed and discussed as well. Specifically, this report examines those companies and products which are actively developing and marketing microscopy devices and supplies in market segments which have the potential for growth rates above 5% per year over the next five years. It continues to examine those microscopy devices operated as light, confocal, electron and scanning probe microscopes. Also analyzed are applications for certain microscope technology platforms such as semi-conductor processing systems and automated imaging systems. Concentration is centered on an overview of individual microscopy markets, which are believed to possess the elements that will lead to sustained growth rates for the foreseeable future. This report assesses the current status of each market, makes projections for market size, discusses the market strategies of leading companies in each market segment, and evaluates the forces that underlie the high growth of each segment. Additionally, there's an overview of the instruments and supplies marketed by major companies in each market segment. Analysis of the market size, growth rates, and market components for instruments used for microscopy are also discussed.
Minimally invasive medical robotics, imaging & visualization systems & surgic...Ron Ethell
The MIS market is expected to grow at a fast rate with a CAGR of 8.2% and is expected to reach $35.5 billion by 2016. The surgical instruments segment commanded the larger share; i.e. 38.4%, of the global minimally invasive surgical devices market in 2011. This growth has been primarily attributed to the increased usage of these devices and instruments in MIS procedures. Devices such as guiding catheters and guidewires as well as balloons have been widely used in interventional angioplasty and peripheral extremity MIS procedures. Numerous innovations in the technologies of devices such as balloons have added to the growth in the market.
The total global value for the fiber optic connector (FOC) market in 2010 is an estimated $1.9 billion. In 2011, global value is projected to increase to more than $1.9 billion, as the global economy begins to improve.
Datamonitor's Suncare: Global Industry Guide is an essential resource for top-level data and analysis covering the Suncare industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.Scope of the Report * Contains an executive summary and data on value, volume and segmentation * Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies* Incorporates in-depth five forces competitive environment analysis and scorecards * Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US). * Includes a five-year forecast of the industryHighlightsThe global suncare market grew by 4.3% in 2009 to reach a value of $6,330.6 million.In 2014, the global suncare market is forecast to have a value of $7,911 million, an increase of 25% since 2009.The global suncare market grew by 3.1% in 2009 to reach a volume of 645.9 million units.In 2014, the global suncare market is forecast to have a volume of 755.9 million units, an increase of 17% since 2009.Sun protection is the largest segment of the global suncare market, accounting for 65.4% of the market's total value.Europe accounts for 39.8% of the global suncare market value.L'Oreal S.A. is the leading player in the global suncare market, generating a 13.7% share of the market's value.L'Oreal, Beiersdorf, and Johnson & Johnson are leading players in the global suncare products market, each with a broad portfolio of brands, catering to different consumer groups and price points, with 36.3% of the market share in value termsWhy you should buy this report * Spot future trends and developments * Inform your business decisions * Add weight to presentations and marketing materials * Save time carrying out entry-level researchMarket DefinitionThe suncare market consists of retail sale of sun protection, after-sun and self-tan products. The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2009 annual average exchange rates.
Global LED Driver IC Market for Display & Lighting Applications (2010 ' 2015)ReportLinker.com
Report DescriptionThe Global LED driver IC market is estimated to grow from $1,119.0 million in 2010 to $4,424.0 million in 2015, at an estimated CAGR of 31.6% from 2010 to 2015. Initiatives taken by the government to phase out demand for incandescent bulbs in lieu of high quality picture images, power efficient lighting offered by LED have increased the deployment and usage of LED driver IC in a range of applications such as displays and lighting.Amongst these two applications, the LED driver IC market for lighting applications is expected to grow with a relatively high CAGR of 46.5% from 2010 to 2015. Display application accounted for the largest share; i.e. 80% of the overall the LED driver IC market generating $895.2 million in 2010 and is expected to generate $2,914.0 million in 2015 with a CAGR of 26.6% for the same period.Scope of the reportThis research report categorizes the global LED driver IC market on the basis of different applications and countries; forecasting revenues, and analyzing trends in each of the smart home applications.On the basis of applicationsApplications such as display and lightings are covered in the report.On the basis of geographyNorth America, Europe, Asia-Pacific (APAC), and ROW (Rest of World) are covered in the report.Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide market tables for covering the sub-segments and micro-markets. In addition, the report provides more than 24 company profiles covering all the sub-segments.What makes our reports unique'We provide the longest market segmentation chain in this industry.We provide 10% customization. Our customization will ensure that they necessarily get the market intelligence they are looking for and we get a loyal customer.We conduct detailed market positioning, product positioning, and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.Comprehensive market analysis is carried out for the following sectors:Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.Key questions answeredWhich are the high-growth segments/cash cows and how is the market segmented in terms of applications and materials'What are market estimates and forecasts; which markets are doing well and which are not'Where are the gaps and opportunities; what is driving the market'Which are the key playing fields' Which are the winning edge imperatives'How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines' Who is doing what'Powerful research and analysisThe analysts working with MarketsandMarkets come from renowned publishing and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.
Nanomedicine Market Size, Analysis, Industry Demand, Growth and Forecast To 2...mahadev mahimkar
The Global Nanomedicine Market Research Report 2016 give insights upon the world's major regional market conditions of the Nanomedicine industry which mainly focus upon the main regions which include continents like North America, Europe and Asia and the main countries i.e. United States, Germany, Japan and China.
Global Physician Survey on Stents, Stent-Grafts and Vulnerable Plaque Treatme...ReportLinker.com
This report details the responses of a comprehensive survey conducted of interventional cardiologists, interventional radiologists and cardiac surgeons on product preferences, placement techniques and trends in the use of drug eluting and bare metal stents, bifurcated stents, bioabsorbable stents, stent grafts, vulnerable plaque diagnosis and treatment and endovascular imaging technologies. The Global Physician Survey on Stents, Stent-Grafts and Endovascular Imaging includes: - The United States - Europe - Asia-Pacific - Latin America - Middle East - Africa This report covers: - Number and Type of Stents Placed - Type of Endovascular Imaging Used - Bifurcated Stents and Their Use - Most Important Benefit When Using Bifurcated Stents - Preferred Bifurcated Stent Alternative - Bioabsorbable Stents and Their Use - Most Important Benefit When Using Bioabsorbable Stents - Most Important Bioabsorable Stent Drawback - Most Important Drug-Eluting Stent Concern - Most Effective Drug-Eluting Stent Drug for Combating Restenosis - Stent-Graft Brand Preference - Most Important Construction Feature for Stent-Grafts - Most Important Design Feature for Next Generation Stent-Grafts - The Use of Thoracic Aortic Aneurysm (TAA) Stent-Grafts - Concerns about the Use of TAA Stent-Grafts
Catheters are used in a number of processes, such as: cardiovascular, urological, intravenous, oximetry, thermodilution, suction and wound drainage processes, that involve the administration or drainage of fluids from the body. The global market for catheters is vibrant and continually evolving with significant investments to improve the capabilities of existing catheters, improve safety features and identify new medical applications. The growing number of aged people undergoing diagnostic and therapeutic procedures is driving increases in catheter sales. Government regulations also play a key role, mainly in the urological catheter segment, as regulations attempt to promote fewer infections among hospitalized patients through more frequent use of catheterization. This TriMark Publications report provides a detailed analysis of the global market for catheters, including central venous catheters (CVC), peripheral venous catheters (PVC), midline catheters (MC), hemodialysis catheters, pulmonary artery catheters, peripheral artery catheters and umbilical catheters. The study also analyzes almost all of the companies known to be marketing, manufacturing or developing catheter products in the U.S. and worldwide. Detailed tables, charts and figures are included with projected sales data by geographic region for the Americas, EMRA (Europe, the Middle East, Russia, Africa) and Asia-Pacific regions.
REPORT HIGHLIGHTSThe global market for sensors was estimated at $56.3 billion in 2010. It is expected to increase to $62.8 billion in 2011 and then to nearly $91.5 billion by 2016, at a compound annual growth rate (CAGR) of 7.8%.The market for biosensors and chemical sensors is expected to experience the highest growth, at a compound annual growth rate (CAGR) of 9.6% during the 5-year period from 2011 to 2016. This sector is expected to be worth $13 billion in 2011 and $21 billion in 2016. Image sensors will experience high growth because of their increased use in smart phones and many other portable devices. The image, flow, and level sensors category is estimated at $18 billion in 2011 and is expected to increase at an 8.5% compound annual growth rate (CAGR) to reach $27 billion in 2016.INTRODUCTIONSensors are an important part of any measurement and automation application. The sensor is responsible for converting physical phenomenon into a quantity measurable by a data-acquisition system. The proliferation of advanced electronic control systems has provided sensor users ongoing advances in sensor accuracy, reliability, response time, robustness, miniaturization, communications capability, and efficiencies. This has fueled research and development in the sensors industry, which in turn creates opportunities for technology advancements that open up new applications for sensors. Application support holds the key to the development of new technologies. What drives the adoption of the core technology in the industrial sector is the availability of a solution that can provide seamless integration into existing automation systems. A need exists for technology and product development to be focused on industrial applications through appropriate additional integration and value-added tests. This must, in turn, be supported by a long-term strategy and road map for the industrial market.STUDY GOAL AND OBJECTIVESThis report studies the role of sensors in various applications, explains the technology and innovation behind sensor development and production, and provides a quantitative and detailed market overview, analyzing major market trends both in terms of region and application sector. In addition, the report examines new developments taking place in the sensors industry with respect to continuous improvements in environmental performance. The report analyzes the market for various sensors as well as for the technologies involved. The market for various emerging technologies in sensors as well as the new products produced using these technologies is also examined.The report also analyzes the various applications of sensors, with a special emphasis on new products in development, and the markets for these products. In addition to new product development, research and development is taking sensor technology to new heights and a closer look into these technologies has been made in this report. This report pinpoints the need for the industry's commitment to continuous improvement in environmental performance and takes a glimpse into a future where the functionality of coatings will be enhanced and transformed from the conventional areas of protection and aesthetics to meet more specific demands.REASONS FOR DOING THE STUDYFor a company to succeed in a competitive market, it must identify product opportunities from the viewpoint of the company's strengths. To this end, it is necessary to understand the size and growth rate of any opportunity and the competitive atmosphere in which the company exists. This report presents the ideal medium to understand the increasing opportunities in the field of sensors, including their applications, and will help a prospective manufacturer, distributor, or user to succeed in this growing industry.INTENDED AUDIENCEThe report will be relevant to the following stakeholders: * Marketing managers identify new market opportunities and develop targeted promotion plans for sensors and allied prod
Smartphones: When is the first and last time you check yours?ReportLinker.com
Nearly half (46%) of Americans say they check their smartphones as soon as they wake up, while they’re still in bed, according to ReportLinker’s survey results. This is especially true of Millennials, 66% of whom say it’s the first thing they do before getting out of bed.
75% of Ameircans say they keep their smartphones active all day and night, and a staggering 83% of Millennials say they do.
In fact, disconnecting can be hard. More than half of Americans say their last check is right before bed – and 13% say they disconnect only after they’ve gotten into bed for the night. Even after they fall asleep, about 10% say they’ll wake up and check it during the night.
European Markets for Interventional Cardiology Devices 2011 (15 Countries)ReportLinker.com
In 2010, the European markets for interventional cardiology devices were valued at over '1.5 billion. In 2010, the fastest growing European market for interventional cardiology devices as the United Kingdom. Over the forecast period, Scandinavia is expected to be the fastest growing market in Europe because it has relatively low DES penetration rates; as these penetration rates increase, they will boost market growth. Growth in countries such as Austria, France, and Switzerland are expected to slow over the forecast period due to decreases in prices across several device markets. The European markets, as defined in this report, include: - Germany, - France, - The United Kingdom (U.K.), - Italy, - Spain, - Benelux (Belgium, Netherlands, and Luxembourg), - Scandinavia (Finland, Denmark, Sweden, and Norway), - Portugal, - Austria and - SwitzerlandThe interventional cardiology market includes: - Drug-eluting stents, - Bare-metal stents, - PTCA balloon catheters, - Interventional coronary catheters and guidewires, - Diagnostic coronary catheters and guidewires, - Coronary introducer sheaths, - Embolic protection devices, - Atherectomy devices, - Coronary vascular closure devices, - Optical coherence tomography (OCT) catheters - Intravascular ultrasound (IVUS) cathetersIn addition, this report covers the emerging markets for vulnerable plaque screening and treatment. Within the European interventional cardiology market, companies such as Boston Scientific, Abbott Laboratories, Cordis and Medtronic lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available for purchase.
European Market for Cardiac Rhythm Management, Electrophysiology & Ablation D...ReportLinker.com
European Market for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 (15 countries) In 2010, the European market for cardiac rhythm management, electrophysiology, and ablation devices was valued at over '2.3 billion ($3.09 billion). The fastest growth was expected in the diagnostic electrophysiology (EP) catheter market and the slowest growth was expected in the external defibrillators market. None of the markets covered in this report are expected to decline over the forecast period. The countries covered in this report include: - Germany - France - U.K - Italy - Spain - Benelux - Scandinavia - Portugal - Austria - SwitzerlandThe market segments in this report include: - Pacemakers, - Implantable cardioverter-defibrillators (ICDs), - Cardiac resynchronization therapy devices (CRTs), - Cardiac leads, - External defibrillators, - Ablation catheters, - Intracardiac echocardiography (ICE) catheters and - Diagnostic electrophysiology (EP) cathetersWithin the cardiac rhythm management, electrophysiology, and ablation device market, companies such as Biotronik, Boston Scientific, Medtronic and St. Jude Medical lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available for purchase.
In 2010, the European market for cardiac surgery devices was valued at over'990 millionThe European markets for cardiac surgery devices includes: - Mechanical Heart Valves - Annuloplasty Repair Devices - Percutaneous Mitral Valve Repair Devices (PMVR) - Percutaneous Aortic Valve Replacement Devices (PAVR) - ONCAB Devices - OPCAB Devices - Endoscopic Vessel Harvesting Devices - Anastomosis Assist Devices - Cardiac Ablation Devices - Transmyocardial Revascularization Devices - Ventricular Assist Devices - Intra-Aortic Balloon Pump Devices - Artificial Heard Devices - Patient Foramen Ovale Devices - Atrial and Ventricular Septal DevicesThe countries covered in this report include: - Germany - France - U.K - Italy - Spain - Benelux - Scandinavia - Portugal - Austria - SwitzerlandWithin the European cardiac surgery device market, companies such as Edwards Lifesciences, Maquet, Medtronic, Sorin and St. Jude lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available for purchase.
Asia-Pacific Markets for Patient Monitoring Devices 2011ReportLinker.com
The total Asia-Pacific patient monitoring market is expected to exceed $598 million by 2017. The Australian home telehealth market experienced the greatest growth in revenues of over 90% in 2010, followed by the Japanese wireless ambulatory telemetry market. Growth is being fueled by efforts of healthcare facilities to decrease costs and compensate for staff shortages by using technology to increase patient mobility and discharge patients sooner. In addition, wireless telemetry monitoring in the Asia-Pacific region was primarily utilized in cardiac care-related areas in 2010. However, expansion of telemetry to other hospital departments that previously did not have monitoring, many of which are low-acuity settings, is expected to drive growth in this market by 2017.The Asia-Pacific markets for patient monitoring devices includes the following countries: - Japan - Australia - South KoreaThe market segments covered in this report include: - Multi-parameter vital sign monitors - Intra-cranial pressure monitors and consumables - Electromyogram devices and consumables - Electroencephalogram monitors - Sleep apnea monitors - Cerebral oximeter monitors and consumables - Fetal and neonatal monitors - Pulse oximeter monitors, consumables and circuit boards - Cardiac output devices and consumables - Blood pressure monitorsWithin the Asia-Pacific patient monitoring market, companies such as Nihon Kohden, GE Healthcare and Philips Healthcare lead the market, among others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available for purchase.
Asia-Pacific Markets for Patient Monitoring Devices 2011ReportLinker.com
The total Asia-Pacific patient monitoring market is expected to exceed $598 million by 2017. The Australian home telehealth market experienced the greatest growth in revenues of over 90% in 2010, followed by the Japanese wireless ambulatory telemetry market. Growth is being fueled by efforts of healthcare facilities to decrease costs and compensate for staff shortages by using technology to increase patient mobility and discharge patients sooner. In addition, wireless telemetry monitoring in the Asia-Pacific region was primarily utilized in cardiac care-related areas in 2010. However, expansion of telemetry to other hospital departments that previously did not have monitoring, many of which are low-acuity settings, is expected to drive growth in this market by 2017.The Asia-Pacific markets for patient monitoring devices includes the following countries: - Japan - Australia - South KoreaThe market segments covered in this report include: - Multi-parameter vital sign monitors - Intra-cranial pressure monitors and consumables - Electromyogram devices and consumables - Electroencephalogram monitors - Sleep apnea monitors - Cerebral oximeter monitors and consumables - Fetal and neonatal monitors - Pulse oximeter monitors, consumables and circuit boards - Cardiac output devices and consumables - Blood pressure monitorsWithin the Asia-Pacific patient monitoring market, companies such as Nihon Kohden, GE Healthcare and Philips Healthcare lead the market, among others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available for purchase.
Asia-Pacific Markets for Patient Monitoring Devices 2011ReportLinker.com
The total Asia-Pacific patient monitoring market is expected to exceed $598 million by 2017. The Australian home telehealth market experienced the greatest growth in revenues of over 90% in 2010, followed by the Japanese wireless ambulatory telemetry market. Growth is being fueled by efforts of healthcare facilities to decrease costs and compensate for staff shortages by using technology to increase patient mobility and discharge patients sooner. In addition, wireless telemetry monitoring in the Asia-Pacific region was primarily utilized in cardiac care-related areas in 2010. However, expansion of telemetry to other hospital departments that previously did not have monitoring, many of which are low-acuity settings, is expected to drive growth in this market by 2017.The Asia-Pacific markets for patient monitoring devices includes the following countries: - Japan - Australia - South KoreaThe market segments covered in this report include: - Multi-parameter vital sign monitors - Intra-cranial pressure monitors and consumables - Electromyogram devices and consumables - Electroencephalogram monitors - Sleep apnea monitors - Cerebral oximeter monitors and consumables - Fetal and neonatal monitors - Pulse oximeter monitors, consumables and circuit boards - Cardiac output devices and consumables - Blood pressure monitorsWithin the Asia-Pacific patient monitoring market, companies such as Nihon Kohden, GE Healthcare and Philips Healthcare lead the market, among others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report is also available for purchase.
European Markets for Anesthesia, Respiratory and Sleep Apnea Devices 2011ReportLinker.com
In 2011, the European Market for Anesthesia, Respiratory and Sleep Management Devices was valued at over $1.4 billion. By 2017, this market is expected to reach almost $2 billion, fueled by growth in the sleep therapy device and ventilator segments, the market is expected to increase over the forecast period. As the population increases in age, the prevalence of sleep disorders is expected to grow accordingly. The European population is also becoming more aware of sleep disorders and the risks associated with not receiving proper treatment, which will drive the total market for anesthesia, respiratory and sleep management devices. In addition, technological advancements such as remote monitoring and homecare devices are expected to further fuel growth. The market segments covered in this report include: - Anesthesia Delivery Units - Anesthesia Delivery Market - Anesthesia Disposables - Ventilators - Nebulizers - Respiratory Disposables - Sleep Diagnostic Devices - Sleep Therapy Devices The countries covered in this report include: - Austria - Benelux - France - Germany - Italy - Portugal - Scandinavia - Spain - Switzerland - The United KingdomThis report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.
This TriMark Publications report deals primarily with the analysis of market segments of microscopes used in clinical and research laboratories. Emphasis is on the U.S. markets; however, the worldwide markets are analyzed and discussed as well. Specifically, this report examines those companies and products which are actively developing and marketing microscopy devices and supplies in market segments which have the potential for growth rates above 5% per year over the next five years. It continues to examine those microscopy devices operated as light, confocal, electron and scanning probe microscopes. Also analyzed are applications for certain microscope technology platforms such as semi-conductor processing systems and automated imaging systems. Concentration is centered on an overview of individual microscopy markets, which are believed to possess the elements that will lead to sustained growth rates for the foreseeable future. This report assesses the current status of each market, makes projections for market size, discusses the market strategies of leading companies in each market segment, and evaluates the forces that underlie the high growth of each segment. Additionally, there's an overview of the instruments and supplies marketed by major companies in each market segment. Analysis of the market size, growth rates, and market components for instruments used for microscopy are also discussed.
Minimally invasive medical robotics, imaging & visualization systems & surgic...Ron Ethell
The MIS market is expected to grow at a fast rate with a CAGR of 8.2% and is expected to reach $35.5 billion by 2016. The surgical instruments segment commanded the larger share; i.e. 38.4%, of the global minimally invasive surgical devices market in 2011. This growth has been primarily attributed to the increased usage of these devices and instruments in MIS procedures. Devices such as guiding catheters and guidewires as well as balloons have been widely used in interventional angioplasty and peripheral extremity MIS procedures. Numerous innovations in the technologies of devices such as balloons have added to the growth in the market.
The total global value for the fiber optic connector (FOC) market in 2010 is an estimated $1.9 billion. In 2011, global value is projected to increase to more than $1.9 billion, as the global economy begins to improve.
Datamonitor's Suncare: Global Industry Guide is an essential resource for top-level data and analysis covering the Suncare industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.Scope of the Report * Contains an executive summary and data on value, volume and segmentation * Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies* Incorporates in-depth five forces competitive environment analysis and scorecards * Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US). * Includes a five-year forecast of the industryHighlightsThe global suncare market grew by 4.3% in 2009 to reach a value of $6,330.6 million.In 2014, the global suncare market is forecast to have a value of $7,911 million, an increase of 25% since 2009.The global suncare market grew by 3.1% in 2009 to reach a volume of 645.9 million units.In 2014, the global suncare market is forecast to have a volume of 755.9 million units, an increase of 17% since 2009.Sun protection is the largest segment of the global suncare market, accounting for 65.4% of the market's total value.Europe accounts for 39.8% of the global suncare market value.L'Oreal S.A. is the leading player in the global suncare market, generating a 13.7% share of the market's value.L'Oreal, Beiersdorf, and Johnson & Johnson are leading players in the global suncare products market, each with a broad portfolio of brands, catering to different consumer groups and price points, with 36.3% of the market share in value termsWhy you should buy this report * Spot future trends and developments * Inform your business decisions * Add weight to presentations and marketing materials * Save time carrying out entry-level researchMarket DefinitionThe suncare market consists of retail sale of sun protection, after-sun and self-tan products. The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2009 annual average exchange rates.
Global LED Driver IC Market for Display & Lighting Applications (2010 ' 2015)ReportLinker.com
Report DescriptionThe Global LED driver IC market is estimated to grow from $1,119.0 million in 2010 to $4,424.0 million in 2015, at an estimated CAGR of 31.6% from 2010 to 2015. Initiatives taken by the government to phase out demand for incandescent bulbs in lieu of high quality picture images, power efficient lighting offered by LED have increased the deployment and usage of LED driver IC in a range of applications such as displays and lighting.Amongst these two applications, the LED driver IC market for lighting applications is expected to grow with a relatively high CAGR of 46.5% from 2010 to 2015. Display application accounted for the largest share; i.e. 80% of the overall the LED driver IC market generating $895.2 million in 2010 and is expected to generate $2,914.0 million in 2015 with a CAGR of 26.6% for the same period.Scope of the reportThis research report categorizes the global LED driver IC market on the basis of different applications and countries; forecasting revenues, and analyzing trends in each of the smart home applications.On the basis of applicationsApplications such as display and lightings are covered in the report.On the basis of geographyNorth America, Europe, Asia-Pacific (APAC), and ROW (Rest of World) are covered in the report.Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide market tables for covering the sub-segments and micro-markets. In addition, the report provides more than 24 company profiles covering all the sub-segments.What makes our reports unique'We provide the longest market segmentation chain in this industry.We provide 10% customization. Our customization will ensure that they necessarily get the market intelligence they are looking for and we get a loyal customer.We conduct detailed market positioning, product positioning, and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.Comprehensive market analysis is carried out for the following sectors:Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.Key questions answeredWhich are the high-growth segments/cash cows and how is the market segmented in terms of applications and materials'What are market estimates and forecasts; which markets are doing well and which are not'Where are the gaps and opportunities; what is driving the market'Which are the key playing fields' Which are the winning edge imperatives'How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines' Who is doing what'Powerful research and analysisThe analysts working with MarketsandMarkets come from renowned publishing and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.
Nanomedicine Market Size, Analysis, Industry Demand, Growth and Forecast To 2...mahadev mahimkar
The Global Nanomedicine Market Research Report 2016 give insights upon the world's major regional market conditions of the Nanomedicine industry which mainly focus upon the main regions which include continents like North America, Europe and Asia and the main countries i.e. United States, Germany, Japan and China.
Global Physician Survey on Stents, Stent-Grafts and Vulnerable Plaque Treatme...ReportLinker.com
This report details the responses of a comprehensive survey conducted of interventional cardiologists, interventional radiologists and cardiac surgeons on product preferences, placement techniques and trends in the use of drug eluting and bare metal stents, bifurcated stents, bioabsorbable stents, stent grafts, vulnerable plaque diagnosis and treatment and endovascular imaging technologies. The Global Physician Survey on Stents, Stent-Grafts and Endovascular Imaging includes: - The United States - Europe - Asia-Pacific - Latin America - Middle East - Africa This report covers: - Number and Type of Stents Placed - Type of Endovascular Imaging Used - Bifurcated Stents and Their Use - Most Important Benefit When Using Bifurcated Stents - Preferred Bifurcated Stent Alternative - Bioabsorbable Stents and Their Use - Most Important Benefit When Using Bioabsorbable Stents - Most Important Bioabsorable Stent Drawback - Most Important Drug-Eluting Stent Concern - Most Effective Drug-Eluting Stent Drug for Combating Restenosis - Stent-Graft Brand Preference - Most Important Construction Feature for Stent-Grafts - Most Important Design Feature for Next Generation Stent-Grafts - The Use of Thoracic Aortic Aneurysm (TAA) Stent-Grafts - Concerns about the Use of TAA Stent-Grafts
Catheters are used in a number of processes, such as: cardiovascular, urological, intravenous, oximetry, thermodilution, suction and wound drainage processes, that involve the administration or drainage of fluids from the body. The global market for catheters is vibrant and continually evolving with significant investments to improve the capabilities of existing catheters, improve safety features and identify new medical applications. The growing number of aged people undergoing diagnostic and therapeutic procedures is driving increases in catheter sales. Government regulations also play a key role, mainly in the urological catheter segment, as regulations attempt to promote fewer infections among hospitalized patients through more frequent use of catheterization. This TriMark Publications report provides a detailed analysis of the global market for catheters, including central venous catheters (CVC), peripheral venous catheters (PVC), midline catheters (MC), hemodialysis catheters, pulmonary artery catheters, peripheral artery catheters and umbilical catheters. The study also analyzes almost all of the companies known to be marketing, manufacturing or developing catheter products in the U.S. and worldwide. Detailed tables, charts and figures are included with projected sales data by geographic region for the Americas, EMRA (Europe, the Middle East, Russia, Africa) and Asia-Pacific regions.
REPORT HIGHLIGHTSThe global market for sensors was estimated at $56.3 billion in 2010. It is expected to increase to $62.8 billion in 2011 and then to nearly $91.5 billion by 2016, at a compound annual growth rate (CAGR) of 7.8%.The market for biosensors and chemical sensors is expected to experience the highest growth, at a compound annual growth rate (CAGR) of 9.6% during the 5-year period from 2011 to 2016. This sector is expected to be worth $13 billion in 2011 and $21 billion in 2016. Image sensors will experience high growth because of their increased use in smart phones and many other portable devices. The image, flow, and level sensors category is estimated at $18 billion in 2011 and is expected to increase at an 8.5% compound annual growth rate (CAGR) to reach $27 billion in 2016.INTRODUCTIONSensors are an important part of any measurement and automation application. The sensor is responsible for converting physical phenomenon into a quantity measurable by a data-acquisition system. The proliferation of advanced electronic control systems has provided sensor users ongoing advances in sensor accuracy, reliability, response time, robustness, miniaturization, communications capability, and efficiencies. This has fueled research and development in the sensors industry, which in turn creates opportunities for technology advancements that open up new applications for sensors. Application support holds the key to the development of new technologies. What drives the adoption of the core technology in the industrial sector is the availability of a solution that can provide seamless integration into existing automation systems. A need exists for technology and product development to be focused on industrial applications through appropriate additional integration and value-added tests. This must, in turn, be supported by a long-term strategy and road map for the industrial market.STUDY GOAL AND OBJECTIVESThis report studies the role of sensors in various applications, explains the technology and innovation behind sensor development and production, and provides a quantitative and detailed market overview, analyzing major market trends both in terms of region and application sector. In addition, the report examines new developments taking place in the sensors industry with respect to continuous improvements in environmental performance. The report analyzes the market for various sensors as well as for the technologies involved. The market for various emerging technologies in sensors as well as the new products produced using these technologies is also examined.The report also analyzes the various applications of sensors, with a special emphasis on new products in development, and the markets for these products. In addition to new product development, research and development is taking sensor technology to new heights and a closer look into these technologies has been made in this report. This report pinpoints the need for the industry's commitment to continuous improvement in environmental performance and takes a glimpse into a future where the functionality of coatings will be enhanced and transformed from the conventional areas of protection and aesthetics to meet more specific demands.REASONS FOR DOING THE STUDYFor a company to succeed in a competitive market, it must identify product opportunities from the viewpoint of the company's strengths. To this end, it is necessary to understand the size and growth rate of any opportunity and the competitive atmosphere in which the company exists. This report presents the ideal medium to understand the increasing opportunities in the field of sensors, including their applications, and will help a prospective manufacturer, distributor, or user to succeed in this growing industry.INTENDED AUDIENCEThe report will be relevant to the following stakeholders: * Marketing managers identify new market opportunities and develop targeted promotion plans for sensors and allied prod
Similar to European Markets for Spinal Implants and VCF 2011 (20)
Smartphones: When is the first and last time you check yours?ReportLinker.com
Nearly half (46%) of Americans say they check their smartphones as soon as they wake up, while they’re still in bed, according to ReportLinker’s survey results. This is especially true of Millennials, 66% of whom say it’s the first thing they do before getting out of bed.
75% of Ameircans say they keep their smartphones active all day and night, and a staggering 83% of Millennials say they do.
In fact, disconnecting can be hard. More than half of Americans say their last check is right before bed – and 13% say they disconnect only after they’ve gotten into bed for the night. Even after they fall asleep, about 10% say they’ll wake up and check it during the night.
This graphic shows Samsung's customers are still loyal: 86% of Samsung Customers would consider Samsung next time they upgrade their smartphone. More info on reportlinker.com/inisght
Allegra Strategies is proud to release the 2012 report on European branded coffee shop market, providing comprehensive research on this fast developing market.The ProjectCaf
Allegra's definitive annual study on the UK branded coffee shop market is now available; with insight from over 25,000 consumers the report provides an authoritative view of the market.Drawing on more than 12 years in-depth research, it is considered to be the bible of the coffee sector.KEY AREAS COVERED' Market size and growth projections for the total UK market' Impact of recent economic downturn on trading performance' Key player profiles, including financial performance, pricing analysis and forecasts' Importance of ethical and sustainability issues' Key success factors and market trends' Opportunities and challenges for suppliers' Consumer coffee consumption patterns' Consumer brand awareness and perceptions of key players' Differences between customer demographics, including age, gender, occupation and location by the reportSOURCE OF INFORMATION' Interviews with CEOs, managing directors, senior managers and store managers of major industry players, including:' leading UK coffee and food-focused chains' major coffee roasters and key equipment suppliers' non-specialist players including department stores, supermarkets, bookstores' leading property companies, letting agents and landlords' local authorities' Online surveys with UK coffee shop visitors' Desk research including: News articles and trade press, the Internet and company websites,industry associations, published accounts, data supplied by operators' In-store observations and analysis
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...ReportLinker.com
WinterGreen Research announces that it has published a new study Wireless Infrastructure: Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2019. Next generation mission critical systems are leveraging new technology. The 2013 study has 554 pages, 245 tables and figures. Worldwide Wireless Infrastructure markets are poised to achieve significant growth as Building out core networks and backhaul for smart phones.A smart phone is not very smart if the infrastructure can't support its applications. In response to the high growth smart phone markets, wireless infrastructure promises to grow dramatically in the near term.. Wireless Infrastructure technologies include WiMax, LTE, 4G and HSPA. These technologies are driving much higher capacity from the base station back to the fiber core. Fiber core is putting extreme pressure on provider's infrastructure and backhaul networks.WinterGreen Research predicts that the dramatic growth of wireless infrastructure is based on the growth of smart phones to a one trillion market by 2019, serving an installed base of 8.5 billion, many people having more than one smart phone. Wireless infrastructure markets at $58 billion in 2012 will be $163 billion by 2019, new markets evolved because of the value that apps provide to smart phones, mobile devices, tablets, and the Internet of things.According to Susan Eustis, lead author of the study, 'Wireless Infrastructure is being installed to upgrade core networks and upgrade backhaul and base stations to make systems more modern. Infrastructure for the Internet and for smart mobile devices creates demand for more sophisticated web development and web applications that in turn depend on more sophisticated infrastructure. Everything is going mobile. This evolution is driven by mobile smart phones and tablets that provide universal connectivity. Modern systems represent a significant aspect of Internet market evolution.'The proportions of wireless infrastructure market industry segments are expected to remain much as they are, with the small cells and femtocells achieving strong growth on the access side, the core infrastructure must be upgraded to support the added backhaul backbone infrastructure. Wireless apps are expected to achieve $37 trillion revenue by 2019. This unbelievable growth occurs as the Internet is expanded to implement the interconnection of everything.Digital devices proliferate, machine to machine capabilities vastly expand instrumentation. The digital devices become the engine of a world economy, with apps collecting pennies a day for millions of apps from 8.5 billion people with smart phones by 2019.
Global Electric Resistance Welded Pipes IndustryReportLinker.com
This report analyzes the worldwide markets for Electric Resistance Welded Pipes in Thousand Tons by the following Product Segments: Mechanical Steel Tubing, Structural Tubing, Structural Steel Pipes, Pressure Tubing, Standard Pipes, Oil Country Tubular Goods, and Line Pipes. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 181 companies including many key and niche players such as Al Jazeera Steel Products Company SAOG, Arabian Pipes Company, ArcelorMittal SA, ERW Pipes Portfolio of ArcelorMittal ChelPipe, Choo Bee Metal Industries Berhad, EVRAZ North America, JFE Steel Corporation, Maharashtra Seamless Limited, Melewar Industrial Group Berhad, Nippon Steel & Sumitomo Metal Corporation, Northwest Pipe Company, OAO TMK, TMK IPSCO, PT Bakrie Pipe Industries, Salzgitter Mannesmann Line Pipe GmbH, Tata Steel Europe, Techint Group SpA, Tenaris S.A., TenarisSiderca, Ternium S.A., United States Steel Corporation, United Metallurgical Company /OMK, Welspun Corp Ltd., Wheatland Tube Company, and Select Products of Wheatland Tube Company. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
This report analyzes the worldwide markets for Wireless Gaming in US$ Million by the following Product Segments: Messaging Based Wireless Gaming, Browser/Web Based Wireless Gaming, and Downloadable Wireless Gaming. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. The report profiles 90 companies including many key and niche players such as Blockdot, Inc., DeNA Co., Ltd., Electronic Arts, Inc., Gameloft SA,GAMEVIL, GREE International, Inc., Glu Mobile Inc., GigaMedia Limited, HandyGames, I-play, Itsmy
Hyperalgesia Global Clinical Trials Review, H1, 2013ReportLinker.com
Hyperalgesia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Hyperalgesia Global Clinical Trials Review, H1, 2013" provides data on the Hyperalgesia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperalgesia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hyperalgesia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Genital Herpes Global Clinical Trials Review, H1, 2013ReportLinker.com
Genital Herpes Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Genital Herpes Global Clinical Trials Review, H1, 2013" provides data on the Genital Herpes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Genital Herpes. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Genital Herpes. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
The Future of Direct Communications Technologies and Proximity-based Applicat...ReportLinker.com
Overview: There are a number of technologies that may be deployed that all provide the ability for devices to "discover" one another, although over different distances ranging from centimeters (Near Field Communications), to meters (Bluetooth), to 10s of meters (Wi-Fi). They also all provide the ability for the devices to communicate directly with one another without a centralized network. Some of these use direct communication as their primary mode of communication e.g. NFC or RFID. Others are more traditional networks which provide direct communication ability as an adjunct to their primary network functions e.g. LTE-Direct or Wi-Fi Direct. Most of the short-term drivers for proximity-based services will be mobile advertising and social networking, especially friend-finder services or dating services, and gaming. In the longer term, other applications will come into play within the scope of the so called Internet of Things. The challenge and opportunity for network operators will be to develop new user scenarios and even new business models to generate revenues from these services. This research uncovers opportunities that will be both beneficial and disruptive to the existing ecosystem and value chain. This research is must reading for any company that is considering offerings within proximity and direct communications and any company that wants to stay ahead of the crowd in terms of preparation for these disruptive technologies. Target Audience: ' Mobile network operators' Industry verticals of all types' Wireless device manufacturers' Network infrastructure companies' Advertising agencies, brands, and merchants' Social networks, advertising, and content providers' Proximity, location, and direct communications vendors Key Report Benefits: ' Market forecasts for each significant technology/solution approach' Recognize the upcoming role and importance of LTE Direct compared to other solutions' Analysis of the major vendors focused on proximity and direct communications solutions' Understand the relationship between proximity, direct communications and the Internet of Things' Understand the technical and business-related differences between proximity/presence and location' Identify each of the major technologies/solutions for proximity detection, location determination, and direct communications' Evaluation of the market for major applications including public safety, social networking, advertising, the Internet of Things, and general location services Select Companies in Report: ' 3M Company' Alcatel-Lucent' iSIGN' LG' Nokia' Samsung' Qualcomm' Verizon Wireless
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...ReportLinker.com
This new 970-page comprehensive five-country report from Venture Planning Group is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.The $4.5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of and cost-effective automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next five years.
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...ReportLinker.com
This new 900-page five-country market intelligence and technology assessment report from Venture Planning Group will help current suppliers and potential market entrants identify and evaluate emerging opportunities and develop effective strategic responses. The report explores future trends in major European countries (France, Germany, Italy, Spain, UK); provides estimates of the specimen, test and sales volumes, as well as major suppliers sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. However, this evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.
Bradycardia Global Clinical Trials Review, H1, 2013ReportLinker.com
Bradycardia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Bradycardia Global Clinical Trials Review, H1, 2013" provides data on the Bradycardia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bradycardia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bradycardia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013" provides data on the Acid Indigestion / Heartburn/ Pyrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acid Indigestion / Heartburn/ Pyrosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acid Indigestion / Heartburn/ Pyrosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
European Markets for Spinal Implants and VCF 2011
Published on January 2011
Report Summary
iData's comprehensive European Markets for Spinal Implants and VCF 2010 report is the industry leading research report for
actionable market intelligence in the changing and exciting European spine industry. This report denotes key data points, market
trends, and in-depth analysis for the following market segments:
- Cervical fusion,
- Thoracolumbar fusion,
- Interbody fusion (including stand-alone interbody devices),
- Vertebroplasty,
- Kyphoplasty,
- Artificial discs,
- Interspinous distraction devices,
- Dynamic stabilization,
- Annular repair,
- Nucleus replacement,
- Facet arthroplasty and lumbar and
- Cervical electrical stimulation devices.
This report also includes key data from the minimally invasive spinal (MIS) fusion market, including XLIF, AxiaLIF, GLIF, DLIF, MIS
PLIF and MIS TLIF approaches.
The report covers:
- Austria
- Benelux
- France
- Germany
- Portugal
- Scandinavia
- Spain
- Switzerland
- The United Kingdom
The European spinal implant markets are expected to exceed '1 billion by 2017,
driven by growth in non-fusion devices. Within the European spinal implant market, companies such as Depuy, Medtronic, Stryker,
Synthes and Zimmer lead the market, among others. This report provides a comprehensive and detailed analysis of market revenues
by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed
competitive analysis, including manufacturer market shares and product portfolios.
The executive summary of this report is also available.
European Markets for Spinal Implants and VCF 2011 (From Slideshare) Page 1/17
2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Table of Content
TABLE OF CONTENTS
EXECUTIVE SUMMARY 1
1.1 TOTAL EUROPEAN SPINAL IMPLANT MARKETS .. 1
1.2 THORACOLUMBAR FIXATION MARKET 2
1.3 CERVICAL FIXATION MARKET.. 3
1.4 INTERBODY FUSION MARKET 4
1.5 DYNAMIC STABILIZATION MARKET.. 5
1.6 ARTIFICIAL DISC MARKET.. 6
1.7 SPINAL VERTEBRAL COMPRESSION FRACTURE MARKET .. 7
1.8 COMPETITIVE ANALYSIS . 8
RESEARCH METHODOLOGY.. 9
2.1 RESEARCH SCOPE 9
2.2 IDATA'S 9-STEP METHODOLOGY 9
Step 1: Project Initiation & Team Selection 10
Step 2: Prepare Data Systems and Perform Secondary Research 11
Step 3: Preparation for Interviews & Questionnaire Design . 12
Step 4: Performing Primary Research 13
Step 5: Research Analysis: Establishing Baseline Estimates . 15
Step 6: Market Forecast and Analysis 15
Step 7: Identify Strategic Opportunities 17
Step 8: Final Review and Market Release 18
Step 9: Customer Feedback and Market Monitoring.. 19
EUROPEAN SPINAL IMPLANT MARKETS . 20
3.1 INTRODUCTION .. 20
3.2 CURRENCY EXCHANGE RATE. 27
3.3 MARKET OVERVIEW 28
3.4 MARKET BY SEGMENT 31
3.5 TREND ANALYSIS BY SEGMENT 37
3.6 MARKET BY COUNTRY .. 41
3.7 MARKET DRIVERS & LIMITERS . 45
3.7.1 Market Drivers 45
3.7.2 Market Limiters.. 46
3.8 COMPETITIVE ANALYSIS .. 49
3.8.1 Leading Competitors 49
3.8.2 Market Concentration. 55
3.9 MERGERS AND ACQUISITIONS 56
THE HUMAN SPINE. 58
4.1 BASIC ANATOMY.. 58
4.2 SPINAL PATHOLOGY & DISORDERS. 61
4.2.1 Degenerative Disc Disease .. 61
European Markets for Spinal Implants and VCF 2011 (From Slideshare) Page 2/17
4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
7.3.3 U.K. 181
7.3.4 Spain . 186
7.3.5 Italy 191
7.3.6 Benelux (Belgium, Netherlands, Luxembourg) 196
7.3.7 Scandinavia (Denmark, Finland, Sweden, Norway). 210
7.3.8 Switzerland. 219
7.3.9 Austria.. 224
7.3.10 Portugal 229
7.4 MARKET DRIVERS AND LIMITERS . 234
7.4.1 Market Drivers. 234
7.4.2 Market Limiters 235
INTERBODY FUSION MARKET. 238
8.1 INTRODUCTION 238
8.1.1 Material Type 240
8.1.2 Minimally Invasive Approaches.. 241
8.2 MARKET OVERVIEW. 245
8.3 MARKET ANALYSIS AND FORECAST. 252
8.3.1 Germany.. 252
8.3.2 France.. 257
8.3.3 U.K. 262
8.3.4 Spain . 267
8.3.5 Italy 272
8.3.6 Benelux. 277
8.3.7 Scandinavia 291
8.3.8 Switzerland. 305
8.3.9 Austria.. 310
8.3.10 Portugal 315
8.4 MARKET DRIVERS AND LIMITERS . 320
8.4.1 Market Drivers. 320
8.4.2 Market Limiters 322
EUROPEAN SPINAL FUSION MARKETS: COMPETITIVE ANALYSIS.. 325
9.1 INTRODUCTION 325
9.2 COMPETITIVE ANALYSIS 326
9.2.1 Total European Markets . 326
9.2.2 Germany.. 332
9.2.3 France.. 332
9.2.4 U.K. 333
9.2.5 Spain . 333
9.2.6 Italy 334
9.2.7 Benelux. 334
9.2.8 Scandinavia 335
9.2.9 Switzerland. 336
9.2.10 Austria 337
9.2.11 Portugal 337
DYNAMIC STABILIZATION MARKET. 338
10.1 INTRODUCTION . 338
10.2 MARKET OVERVIEW.. 339
10.3 MARKET ANALYSIS AND FORECAST.. 347
European Markets for Spinal Implants and VCF 2011 (From Slideshare) Page 4/17
5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
10.3.1 Posterior Dynamic Stabilization Market by Country 347
10.3.2 Interspinous Dynamic Stabilization Market by Country.. 354
10.4 MARKET DRIVERS AND LIMITERS .. 361
10.4.1 Market Drivers.. 361
10.4.2 Market Limiters. 362
10.5 COMPETITIVE ANALYSIS . 364
ARTIFICIAL DISC MARKET. 369
11.1 INTRODUCTION . 369
11.2 MARKET OVERVIEW.. 370
11.3 MARKET ANALYSIS AND FORECAST.. 377
11.3.1 Lumbar Artificial Disc Market by Country. 377
11.3.2 Cervical Artificial Disc Market by Country 385
11.4 MARKET DRIVERS AND LIMITERS .. 392
11.4.1 Market Drivers.. 392
11.4.2 Market Limiters. 394
11.5 COMPETITIVE ANALYSIS . 396
SPINAL VCF MARKET .. 400
12.1 INTRODUCTION . 400
12.1.1 Percutaneous Vertebroplasty. 401
12.1.2 Percutaneous Vertebral Augmentation Including Kyphoplasty 402
12.1.3 Effects of New England Journal of Medicine Publication .. 403
12.2 MARKET OVERVIEW.. 404
12.3 MARKET ANALYSIS AND FORECAST.. 411
12.3.1 PVA Market by Country 411
12.3.2 Vertebroplasty Market by Country . 419
12.4 MARKET DRIVERS AND LIMITERS .. 426
12.4.1 Market Drivers.. 426
12.4.2 Market Limiters. 428
12.5 COMPETITIVE ANALYSIS . 431
12.5.1 Leading Companies and Products .. 431
12.5.2 Emerging Companies and Products .. 436
ABBREVIATIONS 438
APPENDIX: MINIMALLY INVASIVE FUSION 439
14.1 INTRODUCTION . 439
14.2 MARKET ANALYSIS AND FORECAST.. 442
LIST OF FIGURES
Figure 3-1: Exchange Rate between Selected European Currencies and the Euro,
2010 .. 27
Figure 3-2: Total Spinal Implant Market, Europe, 2007 ' 2017 ('M) . 28
Figure 3-3: Total Spinal Implant Market, Europe, 2007 ' 2017 (US$M) .. 29
Figure 3-4: Total Spinal Implant Market by Segment, Europe, 2007 ' 2017
('M).. 32
Figure 3-5: Total Spinal Implant Market by Segment, Europe, 2007 ' 2017
(US$M) 33
Figure 3-6: Spinal Implant Market Growth Rates by Segment, Europe,
2007 ' 2017 39
European Markets for Spinal Implants and VCF 2011 (From Slideshare) Page 5/17
6. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Figure 3-7: Spinal Implant Market by Country, Europe, 2007 ' 2017 ('M) . 42
Figure 3-8: Spinal Implant Market by Country, Europe, 2007 ' 2017 (US$M) .. 43
Figure 3-9: Drivers and Limiters, Spinal Implant Market, Europe, 2010 .. 48
Figure 3-10: Leading Competitors, Spinal Implant Market, Europe, 2010 53
Figure 5-1: European Price Index for Fusion Devices by Country, 2010 .. 68
Figure 6-1: Total Thoracolumbar Fixation Procedures by Indication, Europe,
2007 ' 2017 83
Figure 6-2: Total Thoracolumbar Fixation ASPs by Indication, Europe,
2007 ' 2017 ('M) 84
Figure 6-3: Total Thoracolumbar Fixation ASPs by Indication, Europe,
2007 ' 2017 (US$M) . 84
Figure 6-4: Total Thoracolumbar Fixation Market by Indication, Europe,
2007 ' 2017 (') 85
Figure 6-5: Total Thoracolumbar Fixation Market by Indication, Europe,
2007 ' 2017 (US$).. 85
Figure 6-6: Thoracolumbar Fixation Procedures by Indication, Germany,
2007 ' 2017 90
Figure 6-7: Thoracolumbar Fixation ASP by Indication, Germany, 2007 ' 2017
(') .. 91
Figure 6-8: Thoracolumbar Fixation ASP by Indication, Germany, 2007 ' 2017
(US$) 91
Figure 6-9: Thoracolumbar Fixation Market by Indication, Germany,
2007 ' 2017 ('M) 92
Figure 6-10: Thoracolumbar Fixation Market by Indication, Germany,
2007 ' 2017 (US$M) . 92
Figure 6-11: Thoracolumbar Fixation Procedures by Indication, France,
2007 ' 2017 95
Figure 6-12: Thoracolumbar Fixation ASP by Indication, France, 2007 ' 2017
(') .. 96
Figure 6-13: Thoracolumbar Fixation ASP by Indication, France 2007 ' 2017
(US$) 96
Figure 6-14: Thoracolumbar Fixation Market by Indication, France, 2007 ' 2017
('M).. 97
Figure 6-15: Thoracolumbar Fixation Market by Indication, France, 2007 ' 2017
(US$M) 97
Figure 6-16: Thoracolumbar Fixation Procedures by Indication, U.K.,
2007 ' 2017. 100
Figure 6-17: Thoracolumbar Fixation ASP by Indication, U.K., 2007 ' 2017 (')101
Figure 6-18: Thoracolumbar Fixation ASP by Indication, U.K., 2007 ' 2017
(US$) . 101
Figure 6-19: Thoracolumbar Fixation Market by Indication, U.K., 2007 ' 2017
('M) 102
Figure 6-20: Thoracolumbar Fixation Market by Indication, U.K., 2007 ' 2017
(US$M) . 102
Figure 6-21: Thoracolumbar Fixation Procedures by Indication, Spain,
2007 ' 2017. 105
Figure 6-22: Thoracolumbar Fixation ASP by Indication, Spain, 2007 ' 2017
(') 106
European Markets for Spinal Implants and VCF 2011 (From Slideshare) Page 6/17
7. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Figure 6-23: Thoracolumbar Fixation ASP by Indication, Spain 2007 ' 2017
(US$) . 106
Figure 6-24: Thoracolumbar Fixation Market by Indication, Spain, 2007 ' 2017
('M) 107
Figure 6-25: Thoracolumbar Fixation Market by Indication, Spain, 2007 ' 2017
(US$M) . 107
Figure 6-26: Thoracolumbar Fixation Procedures by Indication, Italy,
2007 ' 2017. 110
Figure 6-27: Thoracolumbar Fixation ASP by Indication, Italy, 2007 ' 2017
(') 111
Figure 6-28: Thoracolumbar Fixation ASP by Indication, Italy, 2007 ' 2017
(US$) . 111
Figure 6-29: Thoracolumbar Fixation Market by Indication, Italy, 2007 ' 2017
('M) 112
Figure 6-30: Thoracolumbar Fixation Market by Indication, Italy, 2007 ' 2017
(US$M) . 112
Figure 6-31: Thoracolumbar Fixation Procedures by Indication, Benelux,
2007 ' 2017. 115
Figure 6-32: Total Thoracolumbar Fixation Procedures by Country, Benelux,
2007 ' 2017. 115
Figure 6-33: Thoracolumbar Fixation Market by Indication, Benelux,
2007 ' 2017 ('M) . 116
Figure 6-34: Thoracolumbar Fixation Market by Indication, Benelux,
2007 ' 2017 (US$M) .. 116
Figure 6-35: Total Thoracolumbar Fixation Market by Country, Benelux,
2007 ' 2017 ('M) . 117
Figure 6-36: Total Thoracolumbar Fixation Market by Country, Benelux,
2007 ' 2017 (US$M) .. 117
Figure 6-37: Thoracolumbar Fixation Procedures by Indication, Belgium,
2007 ' 2017. 121
Figure 6-38: Thoracolumbar Fixation ASP by Indication, Belgium, 2007 ' 2017
(') 122
Figure 6-39: Thoracolumbar Fixation ASP by Indication, Belgium, 2007 ' 2017
(US$) . 122
Figure 6-40: Thoracolumbar Fixation Market by Indication, Belgium,
2007 ' 2017 ('M) . 123
Figure 6-41: Thoracolumbar Fixation Market by Indication, Belgium,
2007 ' 2017 (US$M) .. 123
Figure 6-42: Thoracolumbar Fixation Procedures by Indication, Netherlands,
2007 ' 2017. 126
Figure 6-43: Thoracolumbar Fixation ASP by Indication, Netherlands,
2007 ' 2017 (') . 127
Figure 6-44: Thoracolumbar Fixation ASP by Indication, Netherlands,
2007 ' 2017 (US$) 127
Figure 6-45: Thoracolumbar Fixation Market by Indication, Netherlands,
2007 ' 2017 ('M) . 128
Figure 6-46: Thoracolumbar Fixation Market by Indication, Netherlands,
2007 ' 2017 (US$M) .. 128
European Markets for Spinal Implants and VCF 2011 (From Slideshare) Page 7/17
8. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Figure 6-47: Total Thoracolumbar Fixation Procedures by Country, Scandinavia,
2007 ' 2017. 131
Figure 6-48: Total Thoracolumbar Fixation Market by Country, Scandinavia,
2007 ' 2017 ('M) . 132
Figure 6-49: Total Thoracolumbar Fixation Market by Country, Scandinavia,
2007 ' 2017 (US$M) .. 132
Figure 6-50: Total Degenerative Thoracolumbar Fixation Procedures by Country,
Scandinavia, 2007 ' 2017 . 133
Figure 6-51: Total Deformity Thoracolumbar Fixation Procedures by Country,
Scandinavia, 2007 ' 2017 . 133
Figure 6-52: Total Trauma/Tumor Thoracolumbar Fixation Procedures by
Country, Scandinavia, 2007 ' 2017 .. 134
Figure 6-53: Total Degenerative Thoracolumbar Fixation ASP by Country,
Scandinavia, 2007 ' 2017 (') .. 135
Figure 6-54: Total Degenerative Thoracolumbar Fixation ASP by Country,
Scandinavia, 2007 ' 2017 (US$) 135
Figure 6-55: Total Deformity Thoracolumbar Fixation ASP by Country,
Scandinavia, 2007 ' 2017 (') .. 136
Figure 6-56: Total Deformity Thoracolumbar Fixation ASP by Country,
Scandinavia, 2007 ' 2017 (US$) 136
Figure 6-57: Total Trauma/Tumor Thoracolumbar Fixation ASP by Country,
Scandinavia, 2007 ' 2017 (') .. 137
Figure 6-58: Total Trauma/Tumor Thoracolumbar Fixation ASP by Country,
Scandinavia, 2007 ' 2017 (US$) 137
Figure 6-59: Total Degenerative Thoracolumbar Fixation Market by Country,
Scandinavia, 2007 ' 2017 ('M).. 138
Figure 6-60: Total Degenerative Thoracolumbar Fixation Market by Country,
Scandinavia, 2007 ' 2017 (US$M) 138
Figure 6-61: Total Deformity Thoracolumbar Fixation Market by Country,
Scandinavia, 2007 ' 2017 ('M).. 139
Figure 6-62: Total Deformity Thoracolumbar Fixation Market by Country,
Scandinavia, 2007 ' 2017 (US$M) 139
Figure 6-63: Total Trauma/Tumor Thoracolumbar Fixation Market by Country,
Scandinavia, 2007 ' 2017 ('M).. 140
Figure 6-64: Total Trauma/Tumor Thoracolumbar Fixation Market by Country,
Scandinavia, 2007 ' 2017 (US$M) 140
Figure 6-65: Thoracolumbar Fixation Procedures by Indication, Switzerland,
2007 ' 2017. 143
Figure 6-66: Thoracolumbar Fixation ASP by Indication, Switzerland,
2007 ' 2017 (') . 144
Figure 6-67: Thoracolumbar Fixation ASP by Indication, Switzerland,
2007 ' 2017 (US$) 144
Figure 6-68: Thoracolumbar Fixation Market by Indication, Switzerland,
2007 ' 2017 ('M) . 145
Figure 6-69: Thoracolumbar Fixation Market by Indication, Switzerland,
2007 ' 2017 (US$M) .. 145
Figure 6-70: Thoracolumbar Fixation Procedures by Indication, Austria,
2007 ' 2017. 148
European Markets for Spinal Implants and VCF 2011 (From Slideshare) Page 8/17
9. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Figure 6-71: Thoracolumbar Fixation ASP by Indication, Austria, 2007 ' 2017
(') 149
Figure 6-72: Thoracolumbar Fixation ASP by Indication, Austria, 2007 ' 2017
(US$) . 149
Figure 6-73: Thoracolumbar Fixation Market by Indication, Austria, 2007 ' 2017
('M) 150
Figure 6-74: Thoracolumbar Fixation Market by Indication, Austria, 2007 ' 2017
(US$M) . 150
Figure 6-75: Thoracolumbar Fixation Procedures by Indication, Portugal,
2007 ' 2017. 153
Figure 6-76: Thoracolumbar Fixation ASP by Indication, Portugal, 2007 ' 2017
(') 154
Figure 6-77: Thoracolumbar Fixation ASP by Indication, Portugal, 2007 ' 2017
(US$) . 154
Figure 6-78: Thoracolumbar Fixation Market by Indication, Portugal,
2007 ' 2017 ('M) . 155
Figure 6-79: Thoracolumbar Fixation Market by Indication, Portugal,
2007 ' 2017 (US$M) .. 155
Figure 6-80: Drivers and Limiters, Thoracolumbar Fixation Market, Europe,
2010 160
Figure 7-1: Total Cervical Fixation Procedures by Approach, Europe,
2007 ' 2017. 165
Figure 7-2: Total Cervical Fixation ASP by Approach, Europe, 2007 ' 2017
(') 166
Figure 7-3: Total Cervical Fixation ASP by Approach, Europe, 2007 ' 2017
(US$) . 166
Figure 7-4: Total Cervical Fixation Market by Approach, Europe, 2007 ' 2017
('M) 167
Figure 7-5: Total Cervical Fixation Market by Approach, Europe, 2007 ' 2017
(US$M) . 167
Figure 7-6: Cervical Fixation Procedures by Approach, Germany, 2007 ' 2017 172
Figure 7-7: Cervical Fixation ASP by Approach, Germany, 2007 ' 2017 (') 173
Figure 7-8: Cervical Fixation ASP by Approach, Germany, 2007 ' 2017
(US$) . 173
Figure 7-9: Cervical Fixation Market by Approach, Germany, 2007 ' 2017
('M) 174
Figure 7-10: Cervical Fixation Market by Approach, Germany, 2007 ' 2017
(US$M) . 174
Figure 7-11: Cervical Fixation Procedures by Approach, France, 2007 ' 2017 .. 177
Figure 7-12: Cervical Fixation ASP by Approach, France, 2007 ' 2017 (') . 178
Figure 7-13: Cervical Fixation ASP by Approach, France, 2007 ' 2017 (US$) 178
Figure 7-14: Cervical Fixation Market by Approach, France, 2007 ' 2017
('M) 179
Figure 7-15: Cervical Fixation Market by Approach, France, 2007 ' 2017
(US$M) . 179
Figure 7-16: Cervical Fixation Procedures by Approach, U.K., 2007 ' 2017 .. 182
Figure 7-17: Cervical Fixation ASP by Approach, U.K., 2007 ' 2017 (') . 183
Figure 7-18: Cervical Fixation ASP by Approach, U.K., 2007 ' 2017 (US$) 183
European Markets for Spinal Implants and VCF 2011 (From Slideshare) Page 9/17
10. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Figure 7-19: Cervical Fixation Market by Approach, U.K., 2007 ' 2017 ('M) .. 184
Figure 7-20: Cervical Fixation Market by Approach, U.K., 2007 ' 2017 (US$M)184
Figure 7-21: Cervical Fixation Procedures by Approach, Spain, 2007 ' 2017. 187
Figure 7-22: Cervical Fixation ASP by Approach, Spain, 2007 ' 2017 (') 188
Figure 7-23: Cervical Fixation ASP by Approach, Spain, 2007 ' 2017 (US$) . 188
Figure 7-24: Cervical Fixation Market by Approach, Spain, 2007 ' 2017 ('M) . 189
Figure 7-25: Cervical Fixation Market by Approach, Spain, 2007 ' 2017
(US$M) . 189
Figure 7-26: Cervical Fixation Procedures by Approach, Italy, 2007 ' 2017 .. 192
Figure 7-27: Cervical Fixation ASP by Approach, Italy, 2007 ' 2017 (').. 193
Figure 7-28: Cervical Fixation ASP by Approach, Italy, 2007 ' 2017 (US$) 193
Figure 7-29: Cervical Fixation Market by Approach, Italy, 2007 ' 2017 ('M) .. 194
Figure 7-30: Cervical Fixation Market by Approach, Italy, 2007 ' 2017
(US$M) . 194
Figure 7-31: Cervical Fixation Procedures by Approach, Benelux,
2007 ' 2017. 197
Figure 7-32: Cervical Fixation Procedures by Country, Benelux, 2007 ' 2017 .. 197
Figure 7-33: Cervical Fixation Market by Approach, Benelux, 2007 ' 2017
('M) 198
Figure 7-34: Cervical Fixation Market by Approach, Benelux, 2007 ' 2017
(US$M) . 198
Figure 7-35: Cervical Fixation Market by Country, Benelux, 2007 ' 2017
('M) 199
Figure 7-36: Cervical Fixation Market by Country, Benelux, 2007 ' 2017
(US$M) . 199
Figure 7-37: Cervical Fixation Procedures by Approach, Belgium,
2007 ' 2017. 202
Figure 7-38: Cervical Fixation ASP by Approach, Belgium, 2007 ' 2017 (') .. 203
Figure 7-39: Cervical Fixation ASP by Approach, Belgium, 2007 ' 2017
(US$) . 203
Figure 7-40: Cervical Fixation Market by Approach, Belgium, 2007 ' 2017
('M) 204
Figure 7-41: Cervical Fixation Market by Approach, Belgium, 2007 ' 2017
(US$) . 204
Figure 7-42: Cervical Fixation Procedures by Approach, Netherlands,
2007 ' 2017. 206
Figure 7-43: Cervical Fixation ASP by Approach, Netherlands, 2007 ' 2017
(') 207
Figure 7-44: Cervical Fixation ASP by Approach, Netherlands, 2007 ' 2017
(US$) . 207
Figure 7-45: Cervical Fixation Market by Approach, Netherlands, 2007 ' 2017
('M) 208
Figure 7-46: Cervical Fixation Market by Approach, Netherlands, 2007 ' 2017
(US$M) . 208
Figure 7-47: Total Cervical Fixation Procedures by Country, Scandinavia,
2007 ' 2017. 211
Figure 7-48: Total Cervical Fixation Market by Country, Scandinavia,
2007 ' 2017 ('M) . 212
European Markets for Spinal Implants and VCF 2011 (From Slideshare) Page 10/17
11. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Figure 7-49: Total Cervical Fixation Market by Country, Scandinavia,
2007 ' 2017 (US$M) .. 212
Figure 7-50: Anterior Cervical Fixation Procedures by Country, Scandinavia,
2007 ' 2017. 213
Figure 7-51: Posterior Cervical Fixation Procedures by Country, Scandinavia,
2007 ' 2017. 213
Figure 7-52: Anterior Cervical Fixation ASP by Country, Scandinavia,
2007 ' 2017 (') . 214
Figure 7-53: Anterior Cervical Fixation ASP by Country, Scandinavia,
2007 ' 2017 (US$) 214
Figure 7-54: Posterior Cervical Fixation ASP by Country, Scandinavia,
2007 ' 2017 (') . 215
Figure 7-55: Posterior Cervical Fixation ASP by Country, Scandinavia,
2007 ' 2017 (US$) 215
Figure 7-56: Anterior Cervical Fixation Market by Country, Scandinavia,
2007 ' 2017 ('M) . 216
Figure 7-57: Anterior Cervical Fixation Market by Country, Scandinavia,
2007 ' 2017 (US$M) .. 216
Figure 7-58: Posterior Cervical Fixation Market by Country, Scandinavia,
2007 ' 2017 ('M) . 217
Figure 7-59: Posterior Cervical Fixation Market by Country, Scandinavia,
2007 ' 2017 (US$M) .. 217
Figure 7-60: Cervical Fixation Procedures by Approach, Switzerland,
2007 ' 2017. 220
Figure 7-61: Cervical Fixation ASP by Approach, Switzerland, 2007 ' 2017
(') 221
Figure 7-62: Cervical Fixation ASP by Approach, Switzerland, 2007 ' 2017
(US$) . 221
Figure 7-63: Cervical Fixation Market by Approach, Switzerland, 2007 ' 2017
('M) 222
Figure 7-64: Cervical Fixation Market by Approach, Switzerland, 2007 ' 2017
(US$M) . 222
Figure 7-65: Cervical Fixation Procedures by Approach, Austria,
2007 ' 2017. 225
Figure 7-66: Cervical Fixation ASP by Approach, Austria, 2007 ' 2017 (') 226
Figure 7-67: Cervical Fixation ASP by Approach, Austria, 2007 ' 2017 (US$) .. 226
Figure 7-68: Cervical Fixation Market by Approach, Austria, 2007 ' 2017
('M) 227
Figure 7-69: Cervical Fixation Market by Approach, Austria, 2007 ' 2017
(US$M) . 227
Figure 7-70: Cervical Fixation Procedures by Approach, Portugal,
2007 ' 2017. 230
Figure 7-71: Cervical Fixation ASP by Approach, Portugal, 2007 ' 2017 (') .. 231
Figure 7-72: Cervical Fixation ASP by Approach, Portugal, 2007 ' 2017
(US$) . 231
Figure 7-73: Cervical Fixation Market by Approach, Portugal, 2007 ' 2017
('M) 232
Figure 7-74: Cervical Fixation Market by Approach, Portugal, 2007 ' 2017
European Markets for Spinal Implants and VCF 2011 (From Slideshare) Page 11/17
12. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
(US$M) . 232
Figure 7-75: Drivers and Limiters, Cervical Fixation Device Market, Europe,
2010 237
Figure 8-1: Total Interbody Fusion Procedures by Approach, Europe,
2007 ' 2017 (') . 246
Figure 8-2: Total Interbody Fusion ASP by Approach, Europe, 2007 ' 2017
(') 247
Figure 8-3: Total Interbody Fusion ASP by Approach, Europe, 2007 ' 2017
(US$) . 247
Figure 8-4: Total Interbody Fusion Market by Approach, Europe, 2007 ' 2017
('M) 248
Figure 8-5: Total Interbody Fusion Market by Approach, Europe, 2007 ' 2017
(US$M) . 248
Figure 8-6: Interbody Procedures by Approach, Germany, 2007 ' 2017 . 253
Figure 8-7: Interbody ASP by Approach, Germany, 2007 ' 2017 (') .. 254
Figure 8-8: Interbody ASP by Approach, Germany, 2007 ' 2017 (US$) . 254
Figure 8-9: Interbody Market by Approach, Germany, 2007 ' 2017 ('M) . 255
Figure 8-10: Interbody Market by Approach, Germany, 2007 ' 2017 (US$M). 255
Figure 8-11: Interbody Procedures by Approach, France, 2007 ' 2017 258
Figure 8-12: Interbody ASP by Approach, France, 2007 ' 2017 (') . 259
Figure 8-13: Interbody ASP by Approach, France, 2007 ' 2017 (US$) .. 259
Figure 8-14: Interbody Market by Approach, France, 2007 ' 2017 ('M) 260
Figure 8-15: Interbody Market by Approach, France, 2007 ' 2017 (US$M) . 260
Figure 8-16: Interbody Procedures by Approach, U.K., 2007 ' 2017 263
Figure 8-17: Interbody ASP by Approach, U.K., 2007 ' 2017 (') . 264
Figure 8-18: Interbody ASP by Approach, U.K., 2007 ' 2017 (US$) .. 264
Figure 8-19: Interbody Market by Approach, U.K., 2007 ' 2017 ('M) 265
Figure 8-20: Interbody Market by Approach, U.K., 2007 ' 2017 (US$M) . 265
Figure 8-21: Interbody Procedures by Approach, Spain, 2007 ' 2017 . 268
Figure 8-22: Interbody ASP by Approach, Spain, 2007 ' 2017 (') 269
Figure 8-23: Interbody ASP by Approach, Spain, 2007 ' 2017 (US$) . 269
Figure 8-24: Interbody Market by Approach, Spain, 2007 ' 2017 ('M).. 270
Figure 8-25: Interbody Market by Approach, Spain, 2007 ' 2017 (US$M) 270
Figure 8-26: Interbody Procedures by Approach, Italy, 2007 ' 2017 273
Figure 8-27: Interbody ASP by Approach, Italy, 2007 ' 2017 (') . 274
Figure 8-28: Interbody ASP by Approach, Italy, 2007 ' 2017 (US$) 274
Figure 8-29: Interbody Market by Approach, Italy, 2007 ' 2017 ('M) 275
Figure 8-30: Interbody Market by Approach, Italy, 2007 ' 2017 (US$M) . 275
Figure 8-31: Interbody Fusion Procedures by Approach, Benelux,
2007 ' 2017. 278
Figure 8-32: Interbody Fusion Procedures by Country, Benelux, 2007 ' 2017. 278
Figure 8-33: Interbody Fusion Market by Approach, Benelux, 2007 ' 2017
('M) 279
Figure 8-34: Interbody Fusion Market by Approach, Benelux, 2007 ' 2017
(US$M) . 279
Figure 8-35: Interbody Fusion Market by Country, Benelux, 2007 ' 2017
('M) 280
Figure 8-36: Interbody Fusion Market by Country, Benelux, 2007 ' 2017
European Markets for Spinal Implants and VCF 2011 (From Slideshare) Page 12/17
13. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
(US$M) . 280
Figure 8-37: Interbody Procedures by Approach, Belgium, 2007 ' 2017 283
Figure 8-38: Interbody ASP by Approach, Belgium, 2007 ' 2017 (').. 284
Figure 8-39: Interbody ASP by Approach, Belgium, 2007 ' 2017 (US$) 284
Figure 8-40: Interbody Market by Approach, Belgium, 2007 ' 2017 ('M) 285
Figure 8-41: Interbody Market by Approach, Belgium, 2007 ' 2017 (US$M).. 285
Figure 8-42: Interbody Procedures by Approach, Netherlands, 2007 ' 2017. 287
Figure 8-43: Interbody ASP by Approach, Netherlands, 2007 ' 2017 (') .. 288
Figure 8-44: Interbody ASP by Approach, Netherlands, 2007 ' 2017 (US$). 288
Figure 8-45: Interbody Market by Approach, Netherlands, 2007 ' 2017 ('M) . 289
Figure 8-46: Interbody Market by Approach, Netherlands, 2007 ' 2017
(US$M) . 289
Figure 8-47: Total Interbody Fusion Procedures by Country, Scandinavia,
2007 ' 2017. 292
Figure 8-48: Total Interbody Fusion Market by Country, Scandinavia,
2007 ' 2017 ('M) . 293
Figure 8-49: Total Interbody Fusion Market by Country, Scandinavia,
2007 ' 2017 (US$M) .. 293
Figure 8-50: ALIF Procedures by Country, Scandinavia, 2007 ' 2017 294
Figure 8-51: PLIF Procedures by Country, Scandinavia, 2007 ' 2017 . 294
Figure 8-52: TLIF Procedures by Country, Scandinavia, 2007 ' 2017. 295
Figure 8-53: Cervical Interbody Fusion Procedures by Country, Scandinavia,
2007 ' 2017. 295
Figure 8-54: ALIF ASP by Country, Scandinavia, 2007 ' 2017 (') .. 296
Figure 8-55: ALIF ASP by Country, Scandinavia, 2007 ' 2017 (US$) 296
Figure 8-56: PLIF ASP by Country, Scandinavia, 2007 ' 2017 (') .. 297
Figure 8-57: PLIF ASP by Country, Scandinavia, 2007 ' 2017 (US$). 297
Figure 8-58: TLIF ASP by Country, Scandinavia, 2007 ' 2017 (') .. 298
Figure 8-59: TLIF ASP by Country, Scandinavia, 2007 ' 2017 (US$). 298
Figure 8-60: Cervical Interbody Fusion ASP by Country, Scandinavia,
2007 ' 2017 (') . 299
Figure 8-61: Cervical Interbody Fusion ASP by Country, Scandinavia,
2007 ' 2017 (US$) 299
Figure 8-62: ALIF Market by Country, Scandinavia, 2007 ' 2017 ('M). 300
Figure 8-63: ALIF Market by Country, Scandinavia, 2007 ' 2017 (US$M) .. 300
Figure 8-64: PLIF Market by Country, Scandinavia, 2007 ' 2017 ('M) . 301
Figure 8-65: PLIF Market by Country, Scandinavia, 2007 ' 2017 (US$M) 301
Figure 8-66: TLIF Market by Country, Scandinavia, 2007 ' 2017 ('M) . 302
Figure 8-67: TLIF Market by Country, Scandinavia, 2007 ' 2017 (US$M) .. 302
Figure 8-68: Cervical Interbody Fusion Market by Country, Scandinavia,
2007 ' 2017 ('M) . 303
Figure 8-69: Cervical Interbody Fusion Market by Country, Scandinavia,
2007 ' 2017 (US$M) .. 303
Figure 8-70: Interbody Procedures by Approach, Switzerland, 2007 ' 2017 . 306
Figure 8-71: Interbody ASP by Approach, Switzerland, 2007 ' 2017 (') .. 307
Figure 8-72: Interbody ASP by Approach, Switzerland, 2007 ' 2017 (US$). 307
Figure 8-73: Interbody Market by Approach, Switzerland, 2007 ' 2017 ('M) . 308
Figure 8-74: Interbody Market by Approach, Switzerland, 2007 ' 2017
European Markets for Spinal Implants and VCF 2011 (From Slideshare) Page 13/17
14. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
(US$M) . 308
Figure 8-75: Interbody Procedures by Approach, Austria, 2007 ' 2017.. 311
Figure 8-76: Interbody ASP by Approach, Austria, 2007 ' 2017 (') 312
Figure 8-77: Interbody ASP by Approach, Austria, 2007 ' 2017 (US$).. 312
Figure 8-78: Interbody Market by Approach, Austria, 2007 ' 2017 ('M) .. 313
Figure 8-79: Interbody Market by Approach, Austria, 2007 ' 2017 (US$M) 313
Figure 8-80: Interbody Procedures by Approach, Portugal, 2007 ' 2017 316
Figure 8-81: Interbody ASP by Approach, Portugal, 2007 ' 2017 (').. 317
Figure 8-82: Interbody ASP by Approach, Portugal, 2007 ' 2017 (US$) 317
Figure 8-83: Interbody Market by Approach, Portugal, 2007 ' 2017 ('M) 318
Figure 8-84: Interbody Market by Approach, Portugal, 2007 ' 2017 (US$M).. 318
Figure 8-85: Drivers and Limiters, Interbody Fusion Market, 2010.. 324
Figure 9-1: Leading Competitors, Spinal Fusion Market, Europe, 2010 . 330
Figure 9-2: Leading Competitors, Spinal Fusion Market, Benelux, 2010 335
Figure 9-3: Leading Competitors, Spinal Fusion Market, Scandinavia, 2010 336
Figure 10-1: Dynamic Stabilization Procedures by Type, Europe,
2007 ' 2017. 340
Figure 10-2: Dynamic Stabilization ASP by Type, Europe, 2007 ' 2017 (') 341
Figure 10-3 Dynamic Stabilization ASP by Type, Europe, 2007 ' 2017
(US$) . 341
Figure 10-4: Dynamic Stabilization Market by Type, Europe, 2007 ' 2017
('M) 342
Figure 10-5: Dynamic Stabilization Market by Type, Europe, 2007 ' 2017
(US$M) . 342
Figure 10-6: PDS Procedures by Country, Europe, 2007 ' 2017 348
Figure 10-7: PDS ASP by Country, Europe, 2007 ' 2017 (') .. 349
Figure 10-8: PDS ASP by Country, Europe, 2007 ' 2017 (US$) 350
Figure 10-9: PDS Market by Country, Europe, 2007 ' 2017 ('M). 351
Figure 10-10: PDS Market by Country, Europe, 2007 ' 2017 (US$M) 352
Figure 10-11: IDS Procedures by Country, Europe, 2007 ' 2017 .. 355
Figure 10-12: IDS ASP by Country, Europe, 2007 ' 2017 (') . 356
Figure 10-13: IDS ASP by Country, Europe, 2007 ' 2017 (US$) .. 357
Figure 10-14: IDS Market by Country, Europe, 2007 ' 2017 ('M) 358
Figure 10-15: IDS Market by Country, Europe, 2007 ' 2017 (US$M) . 359
Figure 10-16: Drivers and Limiters, Dynamic Stabilization Market, Europe,
2010 363
Figure 10-17: Leading Competitors, Dynamic Stabilization Market, Europe,
2010 367
Figure 11-1: Artificial Disc Procedures by Type, Europe, 2007 ' 2017 .. 371
Figure 11-2: Artificial Disc ASP by Type, Europe, 2007 ' 2017 (') 372
Figure 11-3: Artificial Disc ASP by Type, Europe, 2007 ' 2017 (US$).. 372
Figure 11-4: Artificial Disc Market by Type, Europe, 2007 ' 2017 ('M) .. 373
Figure 11-5: Artificial Disc Market by Type, Europe, 2007 ' 2017 (US$M) 373
Figure 11-6: LAD Procedures by Country, Europe, 2007 ' 2017 379
Figure 11-7: LAD ASP by Country, Europe, 2007 ' 2017 (') . 380
Figure 11-8: LAD ASP by Country, Europe, 2007 ' 2017 (US$) .. 381
Figure 11-9: LAD Market by Country, Europe, 2007 ' 2017 ('M) 382
Figure 11-10: LAD Market by Country, Europe, 2007 ' 2017 (US$M) .. 383
European Markets for Spinal Implants and VCF 2011 (From Slideshare) Page 14/17
15. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Figure 11-11: CAD Procedures by Country, Europe, 2007 ' 2017. 386
Figure 11-12: CAD ASP by Country, Europe, 2007 ' 2017 (') .. 387
Figure 11-13: CAD ASP by Country, Europe, 2007 ' 2017 (US$) 388
Figure 11-14: CAD Market by Country, Europe, 2007 ' 2017 ('M) . 389
Figure 11-15: CAD Market by Country, Europe, 2007 ' 2017 (US$M) .. 390
Figure 11-16: Drivers and Limiters, Artificial Disc Market, Europe, 2010 395
Figure 11-17: Leading Competitors, Artificial Disc Market, Europe, 2010 398
Figure 12-1: VCF Procedures by Type, Europe, 2007 ' 2017.. 405
Figure 12-2: VCF ASP by Type, Europe, 2007 ' 2017 (') 406
Figure 12-3: VCF ASP by Type, Europe, 2007 ' 2017 (US$) . 406
Figure 12-4: VCF Market by Type, Europe, 2007 ' 2017 ('M) .. 407
Figure 12-5: VCF Market by Type, Europe, 2007 ' 2017 (US$M) 407
Figure 12-6: PVA Procedures by Country, Europe, 2007 ' 2017.. 413
Figure 12-7: PVA ASP by Country, 2007 ' 2017 (') .. 414
Figure 12-8: PVA ASP by Country, Europe, 2007 ' 2017 (US$) 415
Figure 12-9: PVA Market by Country, Europe, 2007 ' 2017 ('M) 416
Figure 12-10: PVA Market by Country, Europe, 2007 ' 2017 (US$M) 417
Figure 12-11: Vertebroplasty Procedures by Country, Europe, 2007 ' 2017 420
Figure 12-12: Vertebroplasty ASP by Country, 2007 ' 2017 (') 421
Figure 12-13: Vertebroplasty ASP by Country, Europe, 2007 ' 2017 (US$). 422
Figure 12-14: Vertebroplasty Market by Country, Europe, 2007 ' 2017
('M) 423
Figure 12-15: Vertebroplasty Market by Country, Europe, 2007 ' 2017
(US$M) . 424
Figure 12-16: Drivers and Limiters, VCF Market, Europe, 2010 430
Figure 12-17: Leading Competitors, VCF Market, Europe, 2010 .. 434
Figure 14-1: Total MIS Spinal Implant Market, Europe, 2007 ' 2017 ('M).. 442
Figure 14-2: Total MIS Spinal Implant Market, Europe, 2007 ' 2017 (US$M) 443
LIST OF CHARTS
Chart 1-1: Total Spinal Implant Market, Europe, 2007 ' 2017 ('M) . 1
Chart 1-2: Thoracolumbar Fixation Market by Indication, Europe, 2007 ' 2017.. 2
Chart 1-3: Cervical Fixation Market by Approach, Europe, 2007 ' 2017 ('M) . 3
Chart 1-4: Interbody Fusion Procedures, Europe, 2007 ' 2017. 4
Chart 1-5: Dynamic Stabilization Market by Type, Europe, 2017 .. 5
Chart 1-6: Artificial Disc Market, Europe, 2007 ' 2017 ('M).. 6
Chart 1-7: VCF Procedures by Type, Europe, 2007 ' 2017 7
Chart 1-8: L
European Markets for Spinal Implants and VCF 2011 (From Slideshare) Page 15/17
16. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
European Markets for Spinal Implants and VCF 2011
Product Formats
Please select the product formats and the quantity you require.
Hard Copy--USD 10 995.00 Quantity: _____
1 User License--USD 11 495.00 Quantity: _____
Corporate License--USD 13 995.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
European Markets for Spinal Implants and VCF 2011 (From Slideshare) Page 16/17
17. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
European Markets for Spinal Implants and VCF 2011 (From Slideshare) Page 17/17